Human epidermal growth factor receptor 2/3 (HER2/HER3) expression in higher-grade meningioma

被引：0
|
作者：
Mair, Maximilian
Tomasich, Erwin
Paiato, Christina
Widhalm, Georg
Eckert, Franziska
Sahm, Felix
Hainfellner, Johannes A.
Berghoff, Anna Sophie
Preusser, Matthias
机构：
[1] Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria
[2] Med Univ Vienna, Dept Neurosurg, Vienna, Austria
[3] Med Univ Vienna, Dept Radiat Oncol, Vienna, Austria
[4] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany
[5] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neuropathol, Heidelberg, Germany
[6] Med Univ Vienna, Dept Neurol, Div Neuropathol & Neurochem, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14063
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma
    Mair, Maximilian J.
    Hartenbach, Sabrina
    Tomasich, Erwin
    Maas, Sybren L. N.
    Bosch, Sarah A.
    Widhalm, Georg
    Eckert, Franziska
    Sahm, Felix
    Hainfellner, Johannes A.
    Hartenbach, Markus
    Berghoff, Anna S.
    Preusser, Matthias
    Albert, Nathalie L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [2] A human epidermal growth factor receptor 3 (HER3)-binding nanoparticle targets and kills Herceptin®-resistant human epidermal growth factor receptor 2 (HER2)-positive breast cancer
    Sims, J. D.
    Taguaim, M.
    Hanson, C.
    Cui, X.
    Medina-Kauwe, L. K.
    CANCER RESEARCH, 2013, 73
  • [3] Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
    Broughton, Marianne Nordlund
    Westgaard, Arne
    Paus, Elisabeth
    Oijordsbakken, Miriam
    Henanger, Karoline J.
    Naume, Bjorn
    Bjoro, Trine
    TUMOR BIOLOGY, 2017, 39 (06) : 1 - 11
  • [4] The human epidermal growth factor receptor 2 (HER2)
    Tafe, Laura J.
    Tsongalis, Gregory J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 23 - 30
  • [5] Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3
    Doyle, Hester A.
    Koski, Raymond A.
    Bonafe, Nathalie
    Bruck, Ross A.
    Tagliatela, Stephanie M.
    Gee, Renelle J.
    Mamula, Mark J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (10) : 1559 - 1569
  • [6] Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3
    Hester A. Doyle
    Raymond A. Koski
    Nathalie Bonafé
    Ross A. Bruck
    Stephanie M. Tagliatela
    Renelle J. Gee
    Mark J. Mamula
    Cancer Immunology, Immunotherapy, 2018, 67 : 1559 - 1569
  • [7] Human epidermal growth factor receptor 2 (HER2) expression in urothelial carcinomas of the bladder
    Nalwa, A.
    Elhence, A. B. S. P.
    Bharti, J. Naresh
    Rao, M.
    Choudhary, G. Ram
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S170 - S171
  • [8] Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: Quantitative analysis of HER2 overexpression effects
    Hendriks, BS
    Opresko, LK
    Wiley, HS
    Lauffenburger, D
    CANCER RESEARCH, 2003, 63 (05) : 1130 - 1137
  • [9] HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells
    Hirata, A
    Hosoi, F
    Miyagawa, N
    Ueda, S
    Naito, S
    Fujii, T
    Kuwano, N
    Ono, M
    CANCER RESEARCH, 2005, 65 (10) : 4253 - 4260
  • [10] Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer
    Yun, Chen
    Gang, Li
    Gu Rongmin
    Xu, Wen
    Ming Xuezhi
    Chen Huanqiu
    MOLECULAR CARCINOGENESIS, 2015, 54 (12) : 1700 - 1709
12345